Posts Tagged ‘North America’
Mexican Hospitals Treated Children With Counterfeit Chemotherapy Drugs
An investigation into the corruption of former Governor Javier Duarte has uncovered allegations that children with cancer were treated in state-run hospitals in Veracruz with counterfeit chemotherapy medicines due to budget shortfalls and lack of resources caused by his administration. The BBC reports, that when tested, the counterfeit chemotherapy drugs came back as an inert…
[...]Partnerka, Counterfeit Drugs and the New Counterfeit Spam
The Partnership for Safe Medicines (PSM) has long reported on the growing issue of pharmaceutical spam advertising—and now SophosLab Canada has taken a closer look at the solicitation of counterfeit products online.
[...]Interview Spotlight: Building Pharmaceutical Anti-Counterfeiting Programs
Dr. Frances Richmond from the University of Southern California (USC) School of Pharmacy and Lew Kontnik of Amgen are the organizers of the upcoming “Building Pharmaceutical Anti-Counterfeiting Programs” course, which will take place on Nov. 18 at USC.
[...]The new “Spamalot” – Spam Solicitations for Counterfeit Drugs
On October 13, a USA Today article featured a report released from the antivirus company McAfee. They found that 70 percent of spam in September was from websites advertizing “Canadian pharmaceuticals.” Further, the only thing that made it “Canadian” was the word Canadian and the maple leaves on the spammers’ web page. The increase in counterfeit drug spam may be due to the rising fears surrounding H1N1 flu, as well as the intensity around the topic of healthcare costs.
[...]No Such Thing as a “Safe Country” for Drug Importation
With talks about drug importation continuing in Congress, drug importation supporters argue that if the United States allows importation only from “safe countries,” such as Canada and the United Kingdom, than most of drug safety concerns would be eliminated. However, when it comes to drug importation, there is no such thing as a “safe” country.
[...]Tougher Penalties for Counterfeiters Under Consideration
On June 4, Rep. Steve J. Israel (D-NY) introduced the Counterfeit Enforcement Act of 2009 (H.R. 2726). This proposed legislation, which would amend the Federal Food, Drug and Cosmetic Act, increases penalties for the sale of contraband or counterfeit drugs. If passed, this legislation brings to life many of the ideas that the Partnership for Safe Medicines advocates in the Principles for Drug Safety.
[...]Cheerios… A Threat Larger Than Counterfeit Drugs?
On May 5, the U.S. Food and Drug Administration (FDA) administered a warning against General Mills regarding the claim that Cheerios® Toasted Whole Grain Oat Cereal has the ability to lower cholesterol. Basically, the FDA cited General Mills for marketing Cheerios® as a cholesterol-reducing drug. I believe the FDA’s points are valid and factual, but I have to ask – Shouldn’t our agency watchdog be focusing greater attention on the operators of thousands of Web sites and
[...]Is Drug Safety in the U.S. Moving in the Right Direction?
Protecting the public’s health is an important part of the part of the U.S. Food and Drug Administration (FDA) job. And on May 7, the FDA proposed several measures that would allow the agency to better regulate the safety of Americans’ food and medical products. The FDA request for the President’s fiscal year 2010 budget asks for $3.2 billion to protect and promote public health. This figure, which is a 19 percent increase from the current FDA fiscal year budget, is a significant step towards the direction of a safer pharmaceutical supply chain.
[...]Pharmacists Fight Against Counterfeit Drugs
Earlier this month, the Partnership for Safe Medicines (PSM) released the L.E.A.D.E.R.’s Guide for Pharmacists to encourage pharmacists to take an active role in protecting the supply chain from counterfeit drugs. This effort is one of many to help curb the distribution of harmful and potentially deadly counterfeit drugs. Similarly, the Royal Pharmaceutical Society of Great Britain (RPSGB), Medicines and Healthcare products Regulatory Agency (MHRA) and the Dispensing Doctor’s Association (DDA) issued Counterfeit medicines: Guidance for pharmacists, explaining the background of counterfeit drugs, their production and distribution to pharmacists.
[...]Drug Importation: Small Savings at a Large Cost
Supporters of drug importation like to cite the statistic that if the United States were to permit drug importation, it would reduce total drug spending by $40 billion over 10 years. This figure is from the 2004 Congressional Budget Office (CBO) issue brief on drug importation.
[...]